Tegaserod, a 5‐HT₄ receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

查看全文 作　　者：S.;A.Müller‐Lissner;I.Fumagalli;K.;D.Bardhan;F.Pace;E.Pecher;B.Nault;P.Rüegg 出　　处：《Alimentary Pharmacology & Therapeutics》索引2008年第10期,共0页